Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
26 February 2015
Header
Header image
Highlight of the week

Events Calendar

Countdown - 1 week: EFPIA Annual Meetings 3-5 June 2015
From 03/06/2015 to 05/06/2015 (Luxembourg)

Only 1 week to go - Register Urgently

EFPIA will be holding its 2015 Annual Meetings from 3 to 5 June in Luxembourg. The event provides an unparalleled opportunity to discuss the key issues driving the European pharmaceutical and healthcare agenda as well as network with senior industry and European stakeholders.

PROGRAMME

REGISTRATION

 

Read more

From our blog

From our blog

Neglected Tropical Diseases in the Spotlight
26 February 2015 by Brendan Barnes

Last week our sister organization IFPMA published a status report on efforts to eliminate or control neglected tropical diseases. These are disease that offer few conventional incentives for commercial companies. The patients are often among the world’s poorest people, living in poor countries with limited health infrastructure. Despite this, one in seven people in the world is affected by these diseases.

Read more

Events calendar

Events Calendar

The business of research: Enabling policies for the medicines of tomorrow
On 03/03/2015 (Brussels: Stanhope Hotel, Room Balmoral III)

Philippe De Backer and Sirpa Pietikäinen, Members of the European Parliament will be hosting a Seminar entitled  'The business of research: Enabling policies for the medicines of tomorrow'. A discussion on the impact of public policies on unmet medical needs and patient access to treatment.

Read more

What we are reading

What we are reading

EPHA urges EU Parliament to bring on health concerns to the European Semester
25 February 2015 (European Public Health Alliance)

EPHA has urged members of the Parliament’s Economic and Monetary Affairs (ECON) Committee to consider health in their report on the 2015 Annual Growth Survey, which is part of the EU’s macroeconomic oversight programme known as the European Semester.

The original text of the ECON Committee report does not make any reference to health. The opinion adopted by the ENVI (Environment, Public Health and Food Safety) Committee on 29 January makes a number of suggestions, including: the danger of short-term savings for the mid- to long-terms costs and the future development of high-quality and high-efficiency healthcare systems; the role of the European Semester as a tool for strengthening and safeguarding healthcare systems and; the importance of investing in health, as a sector which represents 8% of the workforce and 10% of EU GDP.

EPHA Letter to MEP Rosati, Rapporteur

EPHA asked the Rapporteur, MEP Rosati (EPP, PL), along with the shadow rapporteurs in the ECON committee to give greater consideration to health. The report is scheduled to be put to the vote at today’s (23 February) meeting of the ECON Committee.

Read more

What we are reading

Give HIV drugs to healthy gay men
26 February 2015 (BBC)

Healthy gay men should be offered daily HIV drugs to prevent infections, say campaigners.

Read more

What we are reading

Pharmaceutical R&D Projects to Prevent and Control Neglected Conditions
26 February 2015 (International Federation of Pharmaceutical Manufacturers & Associations)

The research-based pharmaceutical industry is actively involved in the fight against diseases affecting vulnerable populations. With 186 compounds in development, R&D programs and pipelines show industry’s commitment to these pressing health challenges. Most of these R&D projects are carried out through innovative collaborations with non-industry partners.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail